SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-284262
Filing Date
2023-11-28
Accepted
2023-11-28 16:01:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d605540d424b3.htm 424B3 154997
2 GRAPHIC g605540g13p72.jpg GRAPHIC 38411
  Complete submission text file 0001193125-23-284262.txt   209063
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275636 | Film No.: 231446284
SIC: 2836 Biological Products, (No Diagnostic Substances)